baber/WOPTO huggingface dataset:
Patent CY-1110299-T1 (CY)
Inventor: ENDELMAN KEN
IPC: A63B23/04
Filed: 2010-06-01
Abstract: A reformer exercise apparatus has a head end and a foot end and a pair of spaced apart parallel track members, a movable carriage mounted on the track members for movement between the head and foot end. One or more springs are connected between the carriage and an elastic member anchor bar and carriage stop assembly at the foot end. The anchor bar and carriage stop assembly adjustably positions the carriage, the anchor bar and the elastic members on the tracks to accommodate a wide range of user heights. Each end of the anchor bar is disposed in an elongated slot formed in each track member. The elongated slot has spaced gear teeth shaped openings defining spaced anchor bar stop or lock portions. The anchor bar can be moved between lock portions only when rotated to an unlocked position wherein the bar, coupled to the carriage, can slide along the track within the slot. In addition, the assembly maintains the carriage and anchor bar a predetermined distance apart when the anchor bar is in the unlocked position and maintains a minimum distance between the anchor bar and the carriage when the anchor bar is in the locked position.
Patent CY-1110219-T1 (CY)
Inventor: MAIER JOHANN-GEORG
IPC: B01J8/10
Filed: 2010-07-21
Abstract: An installation for guiding a gas for devices used to treat granular products by drying, film-coating or coating includes: a central distribution channel that can be connected to a gas supplying device and is connected to outlets for the gas, that are arranged at a distance from the central distribution channel in an axial direction, via connection channels. The installation includes a functional channel which is arranged at a distance from the distribution channel and has a plurality of outlets, and the functional channel includes at least two axially interspaced inlet regions, each being connected to the distribution channel via a connection channel. The outlets are arranged, in the axial direction on the functional channel, between the mouth of two connection channels, which are adjacently arranged in the axial direction, in the functional channel.
Patent CY-1111377-T1 (CY)
Title: Μια μεθοδος για την παραγωγη ελαττωματων και εφελκυστικων εναπομενουσων τασεων
Inventor: ELFVING KAI
IPC: G01N1/44
Filed: 2011-04-05
Abstract: Μία μέθοδος η οποία χρησιμοποιείται για την κατασκευή ελεγχόμενων ελαττωμάτων που αντιστοιχούν σε φυσικές ατέλειες και εναπομείνασες τάσεις σε διάφορα είδη δοκιμαστικών κομματιών. Ελαττώματα πανομοιότυπα με φυσικές ατέλειες απαιτούνται για την πιστοποίηση μη καταστρεπτικών δοκιμαστικών (NDT) διαδικασιών. Στην μέθοδο, χρησιμοποιούνται διαδοχικοί, επαναλαμβανόμενοι κύκλοι θέρμανσης ψύξης για τη δημιουργία ελαττωμάτων και εναπομενουσών τάσεων. Το σχήμα του μοτίβου θέρμανσης και ψύξης, η διάρκεια της θέρμανσης και της ψύξης και ο αριθμός θερμικών κύκλων χρησιμοποιούνται για τον έλεγχο του μεγέθους των προσλαμβανομένων ελαττωμάτων και εναπομενουσών τάσεων. Το ελάττωμα αναπτύσσεται χωρίς αρχική ατέλεια ή κάποιον άλλο πυρηνοποιητή. Τα ελαττώματα αντιστοιχούν σε φυσικές ατέλειες σε όρους μορφολογίας και επίσης των σημάτων που προσλαμβάνονται με μεθόδους NDT, και είναι κατάλληλα για χρήση, για παράδειγμα σε κομμάτι πιστοποίησης NDT.
Patent CY-1112302-T1 (CY)
Inventor: ONO KAZUHISA
IPC: C12P7/64
Filed: 2012-02-13
Abstract: The present invention provides a process for producing a highly unsaturated fatty acid-containing lipid which is less expensive than existing ones, which comprises culturing a microorganism belonging to the genus Mortierella with the use of, as a medium carbon source, a saccharified starch, which is less expensive than glucose, does not contribute to an increase in osmotic pressure of the culture medium, and can be utilized by the Mortierella microorganism, and collecting a highly unsaturated fatty acid-containing lipid from the culture.
Patent CY-1112460-T1 (CY)
Inventor: SERNO PETER
IPC: A61P15/10
Filed: 2012-03-08
Abstract: Production of solid medicaments (A) containing vardenafil hydrochoride (I) in the form of the trihydrate involves using (I) of any water content in the production of (A) and converting (I) into the trihydrate form at an intermediate processing stage or in the final product. An independent claim is included for the medicaments (A) (specifically in coated tablet form) obtained by the process. ACTIVITY : Vasotropic. MECHANISM OF ACTION : None given in the source material.
Patent CY-1116877-T1 (CY)
Title: Φαρμακευτικος συνδυασμος
Inventor: STEFANIC MARTIN FRIEDRICH
IPC: A61P1/16
Filed: 2015-11-03
Abstract: Η παρούσα εφεύρεση αφορά σε έναν φαρμακευτικό συνδυασμό που μπορεί να είναι χρήσιμος για τη θεραπεία των ασθενειών οι οποίες περιλαμβάνουν τον κυτταρικό πολλαπλασιασμό, οι οποίες περιλαμβάνουν τη μετανάστευση ή την απόπτωση των κυττάρων μυελώματος, οι οποίες περιλαμβάνουν την αγγειογένεση ή οι οποίες περιλαμβάνουν την ίνωση. Η εφεύρεση αφορά επίσης σε μια μέθοδο για τη θεραπεία των εν λόγω ασθενειών, η οποία περιλαμβάνει την ταυτόχρονη, τη χωριστή ή τη διαδοχική χορήγηση αποτελεσματικών ποσοτήτων ειδικών δραστικών ενώσεων ή/και τη συνδυαστική θεραπεία με θεραπεία ακτινοβολίας, σε μια αναλογία που παρέχει ένα πρόσθετο και συνεργικό αποτέλεσμα, καθώς και στη συνδυασμένη χρήση αυτών των ειδικών ενώσεων ή/και της ακτινοθεραπείας για την κατασκευή αντίστοιχων φαρμακευτικών παρασκευασμάτων συνδυασμού.
Patent CY-1117795-T1 (CY)
Title: Φαρμακευτικες συνθεσεις απαλλαγμενες κιτρικου αλατος οι οποιες περιεχουν ανακινρα
Inventor: FRANSSON JONAS
IPC: A61K38/17
Filed: 2016-07-18
Abstract: Η παρούσα εφεύρεση αναφέρεται σε φαρμακευτικές συνθέσεις οι οποίες περιέχουν ανακίνρα ως δραστική ένωση απουσία κιτρικού νατρίου. Οι εν λόγω φαρμακευτικές συνθέσεις είναι χρήσιμες για τη θεραπεία IL-1 διαμεσολαβούμενων παθήσεων και για την ελάττωση του αλγαισθητικού πόνου κατά τη διάρκεια μιας τέτοιας θεραπείας.
Patent CY-1119475-T1 (CY)
Title: Μονοκλωνικο αντισωμα εναντι ιντερλευκινης-31 σκυλου
Inventor: BAMMERT GARY F
IPC: A61P17/04
Filed: 2017-08-24
Abstract: Παρέχεται απομονωμένο αντίσωμα το οποίο δεσμεύεται ειδικά σε τουλάχιστον μία από ιντερλευκίνη-31 κυνός (IL-31) ή IL-31 αιλουροειδούς. Τέτοια αντισώματα είναι δυνατόν να διατεθούν στη μορφή διαγνωστικών και/ή κτηνιατρικών συνθέσεων χρήσιμων για την αγωγή κνησμώδους και/ή αλλεργικής κατάστασης σε σκύλους ή γάτες.
Patent CY-1121534-T1 (CY)
Title: Ενωσεις διυδροβενζοφουρανιου χρησιμες στην αγωγη του διαβητη και της παχυσαρκιας
Inventor: SASAKI MINORU
IPC: C07D307/81
Filed: 2019-03-27
Abstract: Παρέχονται μία συγχωνευμένη ετεροκυκλική ένωση η οποία έχει μία ανασταλτική δράση έναντι εντεροπεπτιδάσης και χρήση της ένωσης ως ενός φαρμάκου για τη θεραπευτική αγωγή ή την προφύλαξη έναντι της παχυσαρκίας, του σακχαρώδους διαβήτη, κτλ. Συγκεκριμένα, παρέχεται μία ένωση η οποία παριστάνεται με τον ακόλουθο τύπο (I): όπου κάθε σύμβολο είναι όπως ορίζεται εδώ, ή ένα άλας αυτής, και χρήση της ένωσης ως ενός φαρμάκου για τη θεραπευτική αγωγή ή την προφύλαξη έναντι της παχυσαρκίας, του σακχαρώδους διαβήτη, κτλ.
Patent CY-1125055-T1 (CY)
Title: Προσαρμογεας για ρυθμιζομενη συναρμολογηση μιας δομης σε μια βιολογικη βαση
Inventor: NAIMAN VLADIMIR
IPC: A61C8/00
Filed: 2022-02-01
Abstract: Αποκαλύπτεται ένας ιατρικός προσαρμογέας που γενικά διαθέτει ένα σώμα προσαρμογέα που εκτείνεται από ένα άκρο συνδετικού εξαρτήματος προς έναν στυλεό έδρασης. Ο προσαρμογέας περιλαμβάνει περαιτέρω ένα συνδετικό εξάρτημα που εκτείνεται απομακρυνόμενο από το άκρο συνδετικού εξαρτήματος και ένα κονίαμα που εκτείνεται απομακρυνόμενο και ενιαίο με το συνδετικό εξάρτημα, ώστε να καταλήξει στον στυλεό έδρασης. Ο προσαρμογέας επίσης διαθέτει ένα συρρικνούμενο περιλαίμιο που περιλαμβάνει μία επιφάνεια περιλαιμίου και μία οπή περιλαιμίου που εκτείνεται από μία οπή περιλαιμίου προς μία ουρά περιλαιμίου. Ένας κοχλίας περιλαιμίου κοχλιώνεται στην οπή περιλαιμίου έτσι ώστε το περιλαίμιο να αποφεύγεται να συρρικνωθεί και κλειδώνει σε μία επιθυμητή γωνιακή θέση.
Patent GR-890300181-T1 (GR)
Title: Apparatus for reprofiling a railway
Inventor: PANETTI ROMOLO
IPC: E01B31/17
Filed: 1989-01-30
Abstract: It comprises a support carrying at least one grinding unit, this support is constituted by the chassis 1 of a railway vehicle provided at one of its ends with at least two wheels 2 each resting on one of the lines of rails R1, R2 of the track and articulated about at least one axis parallel to the longitudinal axis of the track at its other end on a rigid frame 4 provided with at least two wheels 5. The chassis 1 is guided by the track and defines, at all times, a reference plane for the grinding. Each grinding unit 9, 10, 11 comprises a frame 17 connected to the chassis 1 by the means 23 of displacement in height and in translation of the pivoting axis x-x of this grinding unit. Each grinder 11 is connected to this frame 17 on the one hand by a turntable 15 and on the other hand by means 13 of displacement of the grinder. 
<IMAGE>
Patent HR-P20100366-T1 (HR)
Inventor: FUHRMANN ULRIKE
IPC: C07J21/00
Filed: 2010-06-29
Abstract: Antagonist receptora progesterona naznačen time da je općenite formule I: formula Ipri čemu R1 može biti atom vodika a R2 hidroksilna skupina, ili R1 i R2 zajedno mogu biti okso skupina. Patent sadrži još 23 patentna zahtjeva.
Patent HR-P20110198-T1 (HR)
Inventor: HOFFMAN STUART W
IPC: A61P25/00
Filed: 2011-03-17
Abstract: Progesteron, namijenjen upotrebi u liječenju traumatske ozljede mozga kod ljudskog subjekta, naznačen time što se navedeno liječenje sastoji u konstantnom ili dvorazinskom režimu doziranja progesterona, gdje se terapijski djelotvornu količinu progesterona primijenjuje intravenskom infuzijom na navedenom ljudskom subjektu kako bi se postiglo konačnu razinu progesterona u serumu od otprilike 100 ng/ml do otprilike 1000 ng/ml. Patent sadrži još 17 patentnih zahtjeva.
Patent HR-P20110311-T1 (HR)
Inventor: GULLAPALLI RAMPURNA
IPC: C07D401/14
Filed: 2011-04-29
Abstract: Sol (1-metil-5-[2-(5-trifluorometil-1H-imidazol-2-il)-piridin-4-iloksi]-1H-benzoimidazol-2-il)-(4-trifluorometil-fenil) amina, naznačena time, da se odabire iz skupine koja se sastoji od acetata, tosilata, sukcinata, laktata, malata, sulfata, maleata, citrata, hidroklorida, fosfata, etansulfonata i metansulfonata, te njihovih solvata i/ili hidrata od ovih. Patent sadrži još 14 patentnih zahtjeva.
Patent HR-P20110682-T1 (HR)
Title: Device and process for applying a weld seam as well as film bag
IPC: B31B19/64
Filed: 2011-09-22
Abstract: The apparatus has an ultrasonic source with an ultrasonic hammer (9) and an anvil (8). A press is arranged to provide a pressure on a part of foil sheets (3a, 3b) of a foil bag (1) proximate the ultrasonic source to create weld seams (2) on the foil bag. The anvil includes a weld side with a projection (10), where a portion of the foil bag is clamped between the projection and the ultrasonic source, and the projection includes one depression (11). An independent claim is also included for a method for producing a weld seam on a foil bag.
Patent HR-P20120433-T1 (HR)
Title: Meningococcal vaccine formulations
Inventor: MARIO CONTORNI
IPC: A61K39/095
Filed: 2012-05-23
Abstract: A lyophilised formulation for vaccines against  Neisseria meningitidis  comprises (i) an immunogen for raising an immune response against  N.meningitidis  serogroup B, and (ii) a conjugated capsular saccharide from one or more of  N.meningitidis  serogroups A, C, W135 and/or Y. The lyophilised antigens can be reconstituted into liquid form at the time of use ready for administration to a patient, and reconstitution can use an adjuvant comprising an oil-in-water emulsion. The formulation gives excellent result in terms of both stability and immunogenicity.
Patent SI-1154774-T1 (SI)
Title: Quinazoline derivatives as angiogenesis inhibitors
Inventor: HENNEQUIN LAURENT FRANCOIS AND
IPC: A61P3/10
Filed: 2000-02-08
Abstract: The invention relates to the use of compounds of the formula I:   
wherein ring C is an 8, 9, 10, 12 or 13-membered bicyclic or tricyclic moiety which optionally may contain 1-3 heteroatoms selected independently from O, N and S; Z is -O-, -NH-, -S-, -CH 2 - or a direct bond; n is 0-5; m is 0-3; R 2  represents hydrogen, hydroxy, halogeno, cyano, nitro, trifluoromethyl, C 1-3 alkyl, C 1-3 alkoxy, C 1-3 alkylsulphanyl, -NR 3 R 4  (wherein R 3  and R 4 , which may be the same or different, each represents hydrogen or C 1-3 alkyl), or R 5 X 1 - (wherein X 1  and R 5  are as defined herein; R 1  represents hydrogen, oxo, halogeno, hydroxy, C 1-4 alkoxy, C 1-4 alkyl, C 1-4 alkoxymethyl, C 1-4 alkanoyl, C 1-4 haloalkyl, cyano, amino, C 2-5 alkenyl, C 2-5 alkynyl, C 1-3 alkanoyloxy, nitro, C 1-4 alkanoylamino, C 1-4 alkoxycarbonyl, C 1-4 alkylsulphanyl, C 1-4 alkylsulphinyl, C 1-4 alkylsulphonyl, carbamoyl,  N- C 1-4 alkylcarbamoyl,  N , N -di(C 1-4 alkyl)carbamoyl, aminosulphonyl,  N -C 1-4 alkylaminosulphonyl,  N , N -di(C 1-4 alkyl)ammosulphonyl,  N -(C 1-4 alkylsulphonyl)amino,  N- (C 1-4 alkylsulphonyl)- N -(C 1-4 alkyl)amino,  N , N -di(C 1-4 alkylsulphonyl)amino, a C 3-7 alkylene chain joined to two ring C carbon atoms, C 1-4 alkanoylaminoC 1-4 alkyl, carboxy or a group R 56 X 10  (wherein X 10  and R 56  are as defined herein); and salts thereof, in the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals, processes for the preparation of such compounds, pharmaceutical compositions containing a compound of formula I or a pharmaceutically acceptable salt thereof as active ingredient and compounds of formula I. The compounds of formula I and the pharmaceutically acceptable salts thereof inhibit the effects of VEGF, a property of value in the treatment of a number of disease states including cancer and rheumatoid arthritis.
Patent SI-2124319-T1 (SI)
Title: Electric rotating machine
Inventor: YANAGISAWA YUKIYOSHI
IPC: H02K3/00
Filed: 2009-05-15
Abstract: A lead conductor penetrating portion (18, 18H) that bring out lead conductors to the inner diameter side is formed in a winding holding portion (14) of a clamp ring (12A) for holding a rotor winding (6, 6U, 6D) that overhangs from a rotor core (5), and furthermore a stopper (20) is formed in a lead portion on the inner diameter side of the lead conductor (19, 19A, 19B), and a centrifugal force-resistant member (24) for holding a centrifugal force acting on the lead conductor (19, 19A, 19B) is interposed between the stopper (20) and the inner diameter side of the winding holding portion (14).
Patent DE-3751467-T2 (DE)
Inventor: MURPHY TIMOTHY F
IPC: G01N33/569
Filed: 1987-11-12
Granted: 1996-02-15
Abstract: A plasmid which contains a genetic code for an immunogenic portion which is conserved in many strains of nontypable Haemophilus influenzae and the bacterium containing this plasmid is disclosed. The immunogenic portion is preferably an epitope on an outer membrane protein of H. influenzae. A monoclonal antibody to the immunogenic portion and the hybridoma which will produce the monoclonal antibody is also included. The invention further includes a DNA probe constructed to correspond to the nucleic acids which code for the immunogenic portion. This probe may be labelled with a radioactive marker and may be used as a diagnostic tool to assay various clinical samples for the presence of H. influenzae.
Patent DE-3783237-T2 (DE)
Inventor: SILVESTRINI ROSELLA
IPC: C12Q1/06
Filed: 1987-01-24
Granted: 1993-05-06
Abstract: Kit for use in the determination of the proliferative activity in human tumours, characterized mainly by a container containing, in assembled and lyophilized form, the four basic components (culture medium, antibiotic, serum and radioactive metabolic precursor) necessary to fix the tumoural material fragments rapidly and easily, without any fear of degradation and granting reliable results.
Patent DE-3787199-T2 (DE)
Inventor: STERNER RUDOLPH J
IPC: G11B19/28
Filed: 1987-04-21
Granted: 1994-03-10
Abstract: There is disclosed herein an apparatus and method for generating a first signal related to the rate of change of a second signal. In particular, a system is disclosed for generating a velocity signal in a sampled data servo system. The apparatus uses three track and hold amplifiers one of which is also a difference amplifier to sample the position error signal at selected times. A "present" track and hold amplifier samples and holds the position error signal during the current frame. After this is done, during the same frame, a "summing" track and hold amplifier having its difference inputs coupled to the outputs of the "present" track and hold amplifier and to a "previous" track and hold amplifier samples the difference between the present position error signal and the value of the position error signal during the previous sample frame. This difference divided by the sample period gives the velocity. After the difference value is sampled, the "previous" track and hold amplifier sample is updated to the amplitude of the position error signal during the current frame in preparation for the calculation during the next frame.
Patent DE-3851713-T2 (DE)
Inventor: SANDS ROBERT M
IPC: H04N9/29
Filed: 1988-01-22
Granted: 1995-02-23
Abstract: An image rotation compensation circuit for use with a CRT (14). The compensation circuit includes a winding (22) which encircles the CRT (14) and is oriented transverse to the path of the electron beam (20). A controller (26) is connected to the winding (22) and drives a current through the winding to create a magnetic field. The direction and magnitude of the current may be adjusted by the user to substantially cancel an external magnetic field and thus eliminate any image rotation caused thereby.
Patent DE-3854372-T2 (DE)
Inventor: NAKANO SHOHKICHI
IPC: G01R27/02
Filed: 1988-10-26
Granted: 1996-02-08
Abstract: A conductivity measuring device comprises a low-potential intermediate electrode (6) which is capable of being in connected state by a switch (7) and which is disposed between a couple of measuring electrodes (3, 4) for transmitting and receiving. Each of said electrodes is made contact with a body (1) to be tested so that the conductivities of the surface and the inner portion of said body (1) to be tested can be measured, respectively.
Patent TR-199802032-T2 (TR)
Inventor: AL-JIBOORY MUHAMMED
IPC: C25D5/20
Filed: 1997-04-04
Abstract: Oksitler ve yaglayicilar gibi filmleri bir metal substrattan ayirmak için ilk olarak filmlere filmin substratta parçalamak üzere mekanik ya da termal gerilim uygulanir. Substrat daha sonra karsi polaritede bir baska elektrod elemanini tanimlayan hareketli substrattan ayri elektriksel polaritede bir ya da daha fazla elektrod elemanina sahip bir elektroliz hücresine aktarilir. Enerji, sonik ya da ultrasonik, üretilir ve hareketli substrata odaklanir, böylece filmin altinda metal substratin çukurlu kisimlarinda kavitasyon kabarciklari olusur. Kavitasyon kabarciklari genislediginde ve patladiginda olusan sok dalgasi ve mikrojet islemi film üzerinde metal substrata göre bir kaldirma etkisi yaratir.
Patent TR-199901098-T2 (TR)
Inventor: BRECHT KLAUS
IPC: A41D31/00
Filed: 1997-11-10
Abstract: Bulus, güvenlik giyimi, tercihen bir güvenlik botu tabani, üretimi için polieter-poliüretandan yapilan hücreli kati kalip plastiklerinin kullanimi ile ilgilidir.
Patent TR-199901994-T2 (TR)
Inventor: KELLER CHRISTOPH
IPC: B29C44/12
Filed: 1998-01-23
Abstract: Bulus, yatay elekler için elekler için bir elek çerçevesini ve ayrica bunun üretimine yönelik bir yöntemi kapsamaktadir. Bulusun görevi ankastre elek çerçevesinin islevselliginin iyilestirilmesi ve üretimin kolaylastirilmasidir. Bu görevi, elek çerçevesinin (1) elek latalari (2) da dahil olmak üzere tek bir parça (ve tek islem) halinde PUR köpügünün içine alinmalariyla birlikte, elek dokusunun (4) da ayni sekilde köpügün içine alinmasi ve elek çerçevesinin (1) tercihen bir metal nüve (3) ihtiva etmesiyle yerine getirilmektedir.
Patent AT-E442163-T2 (AT)
Inventor: ROOF MICHAEL
IPC: C07K16/12
Filed: 2004-07-15
Granted: 2009-09-15
Abstract: The present invention relates to Lawsonia intracellularis vaccines and methods for protecting against and diagnosing L. intracellularis infection. The products and processes of the invention are attainable, in part, as the result of an improved method for cultivating large scale supplies of L. intracellularis, including both a novel isolate of L. intracellularis of European origin and a method of preparing a lyophilized product containing the attenuated European isolate as vaccine product.
Patent DE-60005609-T2 (DE)
Inventor: DE NANTEUIL GUILLAUME
IPC: A61K38/05
Filed: 2000-06-15
Granted: 2004-08-05
Abstract: A compound selected from those of formula (I):wherein:R1 represents hydrogen, optionally substituted alkyl, cycloalkyl or heterocycloalkyl or a group of formula (G):wherein A1 represents single, -CH2-, -CH2-CH2- or -N(CH3)- or oxygen or sulphur, and X1 and X2, which may be identical or different, each represent carbon or nitrogen,R represents hydrogen or linear or branched (C1-C6)alkyl, represents a saturated ring having from 4 to 7 ring members,n represents integer wherein 1<=n<=6,Ar represents aryl or heteroaryl,its isomers, N-oxydes and pharmaceutically-acceptable acid or base addition salts thereof.
Patent DE-60006660-T2 (DE)
Inventor: KARAGEOZIAN HAMPAR
IPC: A61K38/47
Filed: 2000-04-28
Granted: 2004-09-30
Abstract: The invention disclosed herein relates to biochemical methods for the elimination of corneal collagen fiber disorganization to improve vision. Disorganization of corneal collagen fibers is seen in corneal scars, corneal opacification and corneal haze. In addition, the invention relates to biochemical methods for the elimination of corneal collagen fiber disorganization resulting from accidental traumatic injury to the cornea and from refractive surgery for such as radial keratotomy (RK), photorefractive keratectomy (PRK), and laser in situ keratomileusis (LASIK) so as to improve visual acuity and quality of vision.
Patent DE-60009956-T2 (DE)
Inventor: DE BRUIJN DICK
IPC: C12N5/074
Filed: 2000-12-27
Granted: 2005-04-28
Abstract: The invention relates to a culture medium for culturing cells, in particular human cells in a process for tissue engineering bone. The medium comprises glucose, a mineral, a vitamin, a growth factor and L-glutamine, wherein the L-glutamine is present in a concentration of at least 300 mg/L.
Patent DE-60012501-T2 (DE)
Inventor: HOTELLIER CHRISTOPHE
IPC: G02C5/22
Filed: 2000-05-05
Granted: 2005-08-04
Abstract: The invention concerns an elastic articulating component for an optical frame, comprising a case (1), a slide (3) arranged inside the case, a locking socket (11) which itself mounted around the slide. The socket has an elastic tab (1) to block the socket relative to the case (1) when the latter is moved relative to an articulating knuckle (13) against the compression of a spring (7). The invention is characterised in that the case (1) has a housing (5) for guiding the slide (3) in translation inside the case, and the elastic tab (19) is inserted into an aperture (21) of the case (10) emerging into the housing (5). This arrangement enables to reduce play when the slide is being guided in translation inside the case and provides greater facility for maintaining the tab in the case. Advantageously, it enables for reduce the width of the case, thereby enhancing the aesthetic appearance of the frame.